News Related to M Ventures

Related coverage linked through entity extraction aliases.

Nucleome Therapeutics Appoints Dr. Michelle Morrow as Chief Scientific Officer

Feb 16, 2026

Nucleome Therapeutics announces Dr. Michelle Morrow as CSO effective February 23, 2026, bringing two decades of drug discovery experience as the company advances lead candidate NTP464 toward IND enabling studies.

Sanofi Ousts CEO Hudson, Appoints Belén Garijo to Fix Drug Pipeline

Feb 13, 2026

Sanofi replaced CEO Paul Hudson with Belén Garijo from Merck KGaA after a stalled turnaround. The company faces pressure to develop drugs to replace blockbuster Dupixent and navigate U.S. vaccine skepticism.